v3.25.2
Condensed Consolidated Statements of Stockholders’ Equity (Unaudited) - USD ($)
Common Stock
Additional Paid In Capital
Accumulated Deficit
Total
Balance at Dec. 31, 2023 $ 1,663 $ 72,879,738 $ (68,797,872) $ 4,083,529
Balance (in Shares) at Dec. 31, 2023 1,663,421      
Equity-based compensation – stock option expense 177,003 177,003
Exercise of warrants $ 2,391 3,821,873 3,824,264
Exercise of warrants (in Shares) 2,391,440      
Equity-based compensation – stock issuances to consultants and employees 48,987 48,987
Inducement expense 4,464,427 4,464,427
Net loss (6,476,560) (6,476,560)
Balance at Mar. 31, 2024 $ 4,054 81,392,028 (75,274,432) 6,121,650
Balance (in Shares) at Mar. 31, 2024 4,054,861      
Balance at Dec. 31, 2023 $ 1,663 72,879,738 (68,797,872) 4,083,529
Balance (in Shares) at Dec. 31, 2023 1,663,421      
Inducement expense       4,464,427
Net loss       (8,934,858)
Balance at Jun. 30, 2024 $ 4,292 82,005,259 (77,732,730) 4,276,821
Balance (in Shares) at Jun. 30, 2024 4,293,681      
Balance at Mar. 31, 2024 $ 4,054 81,392,028 (75,274,432) 6,121,650
Balance (in Shares) at Mar. 31, 2024 4,054,861      
Equity-based compensation – stock option expense 153,391 153,391
Sale of common stock, net of transaction costs $ 238 410,853 411,091
Sale of common stock, net of transaction costs (in Shares) 238,820      
Equity-based compensation – stock issuances to consultants and employees 48,987 48,987
Inducement expense      
Net loss (2,458,298) (2,458,298)
Balance at Jun. 30, 2024 $ 4,292 82,005,259 (77,732,730) 4,276,821
Balance (in Shares) at Jun. 30, 2024 4,293,681      
Balance at Dec. 31, 2024 $ 6,473 86,056,934 (81,995,323) 4,068,084
Balance (in Shares) at Dec. 31, 2024 6,474,588      
Equity-based compensation – stock option expense 93,301 93,301
Equity-based compensation - stock issuances to a vendor and vesting to employee $ 100 143,330 143,430
Equity-based compensation - stock issuances to a vendor and vesting to employee (in Shares) 100,000      
Net proceeds from sale of common stock $ 77 50,571 50,648
Net proceeds from sale of common stock (in Shares) 75,000      
Net loss (2,228,801) (2,228,801)
Balance at Mar. 31, 2025 $ 6,650 86,344,136 (84,224,124) 2,126,662
Balance (in Shares) at Mar. 31, 2025 6,649,588      
Balance at Dec. 31, 2024 $ 6,473 86,056,934 (81,995,323) 4,068,084
Balance (in Shares) at Dec. 31, 2024 6,474,588      
Inducement expense      
Net loss       (4,187,357)
Balance at Jun. 30, 2025 $ 21,535 91,751,821 (86,182,680) 5,590,676
Balance (in Shares) at Jun. 30, 2025 21,534,695      
Balance at Mar. 31, 2025 $ 6,650 86,344,136 (84,224,124) 2,126,662
Balance (in Shares) at Mar. 31, 2025 6,649,588      
Equity-based compensation – stock option expense 75,099 75,099
Exercise of warrants $ 9,477 2,212,455 2,221,932
Exercise of warrants (in Shares) 9,477,240      
Inducement expense      
Equity-based compensation - stock issuances to a vendor and vesting to employee 49,000 49,000
Net proceeds from sale of common stock $ 5,408 3,071,131 3,076,539
Net proceeds from sale of common stock (in Shares) 5,407,867      
Net loss (1,958,556) (1,958,556)
Balance at Jun. 30, 2025 $ 21,535 $ 91,751,821 $ (86,182,680) $ 5,590,676
Balance (in Shares) at Jun. 30, 2025 21,534,695